Skip to main content

Table 3 Estimation of incremental costs as per life saved, per life year saved and per DALY averted in the PRIME

From: Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Estimation of incremental costs

Vaccine price

Scenario 5

Scenario 6

Scenario 7

Scenario 8

Scenario 9

Scenario 10

Scenario 11 (average cost)

Incremental cost per discounted life saved

HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses)

24,490

5,773

20,354

22,061

401

13,711

14,331

Cervarix vaccine with 106.8 US$ for 3 doses

122,510

103,793

118,374

120,081

97,619

111,731

112,351

Gardasil vaccine with 167.4 US$ for 3 doses

186,279

167,561

182,142

183,849

161,388

175,499

176,120

Incremental cost per discounted life year saved

HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses)

1,196

282

994

1,077

20

670

700

Cervarix vaccine with 106.8 US$ for 3 doses

5,983

5,069

5,781

5,865

4,768

5,457

5,487

Gardasil vaccine with 167.4 US$ for 3 doses

9,098

8,184

8,896

8,979

7,882

8,571

8,602

Incremental cost per discounted DALY averted

HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses)

1,103

260

917

994

18

618

645

Cervarix vaccine with 106.8 US$ for 3 doses

5,518

4,675

5,331

5,408

4,397

5,032

5,060

Gardasil vaccine with 167.4 US$ for 3 doses

8,390

7,547

8,203

8,280

7,269

7,904

7,932

  1. Unit cost: US$